ArticleJournal of managed care & specialty pharmacy2022

Cost impact of different treatment regimens of brolucizumab in neovascular age-related macular degeneration: A budget impact analysis.

Zasim Azhar Siddiqui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.